Stock Financial Ratios


NUTR / Nutraceutical International Corp. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price41.80
Volume193,800.00
Market Cap ($M)389.72
Enterprise Value ($M)382.78
Book Value ($M)171.99
Book Value / Share18.40
Price / Book2.27
NCAV ($M)215.69
NCAV / Share23.08
Price / NCAV1.66
Income Statement (mra) ($M)
Revenue232.99
EBITDA29.18
Net Income0.00
Balance Sheet (mrq) ($M)
Cash & Equivalents4.18
Cash / Share0.45
Assets256.46
Liabilities74.22
Quick Ratio1.48
Current Ratio4.65
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.00
Return on Assets (ROA)0.00
Return on Equity (ROE)0.00
Identifiers and Descriptors
CUSIP67060Y101
Central Index Key (CIK)1050007
Industry Groups
SIC 2833 - Medicinal Chemicals and Botanical Products
Share Statistics
Common Shares Outstanding (M)9.25
Scoring Models
Piotroski F Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Inventory Raw Materials Per Share0.00
Liabilities Per Share7.94
Assets Other Current Per Share0.00
Additional Paid In Capital Per Share0.23
Accounts Payable Per Share0.00
Inventory Finished Goods Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Property Plant And Equipment Net Per Share8.79
Retained Earnings Per Share19.31
Cash And Equivalents Per Share0.45
Cash Per Share0.45
Liabilities Current Per Share2.46
Property Plant And Equipment Per Share8.79
Intangibles Per Share3.02
Inventory Work In Progress Per Share0.00
Assets Per Share27.44
Inventory Per Share7.34
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Debt Per Share0.00
Assets Current Per Share10.81
Accumulated Depreciation And Depletion Per Share0.00
Liabilities Other Non Current Per Share0.08
Equity Per Share19.50
Liabilities And Stock Equity Per Share27.44
Goodwill Per Share4.13
Minority Interest Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Assets Other Non Current Per Share0.14
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share2.25

Related News Stories

BRIEF-‍weiss Asset Management reports 8.76 pct passive stake in Nutraceutical International

2017-08-12 reuters
* ‍weiss Asset Management Lp reports 8.76 percent passive stake in Nutraceutical International Corp as on August 4, 2017 - sec filing​ Source text: (bit.ly/2vvmJcG) Further company coverage:

BRIEF-Nutraceutical says U.S. FTC granted early termination of Hart-Scott-Rodino waiting period

2017-06-09 reuters
* Nutraceutical International - on June 7, U.S. FTC granted early termination of Hart-Scott-Rodino waiting period for pending acquisition of co Source text for Eikon: (bit.ly/2rTI1Pg) Further company coverage:

CONN'S INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Conn's, Inc. - CONN

2017-05-27 prnewswire
NEW ORLEANS, May 26, 2017 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Conn's, Inc. (NasdaqGS: CONN).  

Harwood Feffer LLP Announces Investigation of Nutraceutical International Corporation

2017-05-23 prnewswire
NEW YORK, May 23, 2017 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Nutraceutical International Corporation ("Nutraceutical" or the "Company") (NASDAQ: NUTR) concerning the proposed acquisition of the Company by HGGC, LLC ("HGGC").

Risk Arbitrage Today: Will Pandora Be Sold?

2017-05-23 seekingalpha
It is about halftime in the race for music streaming company Pandora Media (NYSE:P) to sell itself. On May 8, Pandora received an offer from private equity company KKR for an $150 million infusion. In return for that sizable payment, KKR would get a board seat and preferred stock in return. The stock would be convertible into common stock at $13.50 per share. That is about 40% above where Pandora has been trading the past few weeks.

CUSIP: 67060Y101